Cargando…

MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma

BACKGROUND: Extracellular vesicles are lipid bilayer vesicles containing protein, messengerRNA and microRNA. Cancer cell-derived extracellular vesicles may be diagnostic and therapeutic targets. We extracted extracellular vesicles from urine of urothelial carcinoma patients and the control group to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuzaki, Kyosuke, Fujita, Kazutoshi, Jingushi, Kentaro, Kawashima, Atsunari, Ujike, Takeshi, Nagahara, Akira, Ueda, Yuko, Tanigawa, Go, Yoshioka, Iwao, Ueda, Koji, Hanayama, Rikinari, Uemura, Motohide, Miyagawa, Yasushi, Tsujikawa, Kazutake, Nonomura, Norio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421878/ https://www.ncbi.nlm.nih.gov/pubmed/28160564 http://dx.doi.org/10.18632/oncotarget.14969

Ejemplares similares

Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2017)

R.E.N.A.L. nephrometry score predicts postoperative recurrence of localized renal cell carcinoma treated by radical nephrectomy
por: Nagahara, Akira, et al.
Publicado: (2015)

Clinical and histopathological effects of presurgical treatment with sunitinib for renal cell carcinoma with inferior vena cava tumor thrombus at a single institution
por: Ujike, Takeshi, et al.
Publicado: (2016)

A novel model to predict positive prostate biopsy based on serum androgen level
por: Ujike, Takeshi, et al.
Publicado: (2017)

Expression level of CXCL7 in peripheral blood cells is a potential biomarker for the diagnosis of renal cell carcinoma
por: Kinouchi, Toshiro, et al.
Publicado: (2017)

MiR-30b-3p and miR-126-3p of urinary extracellular vesicles could be new biomarkers for prostate cancer
por: Matsuzaki, Kyosuke, et al.
Publicado: (2021)

STAT3 expression is a prognostic marker in upper urinary tract urothelial carcinoma
por: Matsuzaki, Kyosuke, et al.
Publicado: (2018)

Serum monocyte fraction of white blood cells is increased in patients with high Gleason score prostate cancer
por: Hayashi, Takuji, et al.
Publicado: (2016)

Results of weekday-on and weekend-off administration schedule of sunitinib therapy for advanced renal cell carcinoma
por: Kawashima, Atsunari, et al.
Publicado: (2018)

Expression of miR-27a-3p is an independent predictive factor for recurrence in clear cell renal cell carcinoma
por: Nakata, Wataru, et al.
Publicado: (2015)

Failure to achieve castrate level of serum testosterone during luteinizing hormone-releasing hormone agonist therapy in a patient with prostate cancer
por: Koh, Yoko, et al.
Publicado: (2020)

The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN
por: Egawa, Hiroshi, et al.
Publicado: (2016)

Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell‐free DNA in upper tract urothelial carcinoma
por: Hayashi, Yujiro, et al.
Publicado: (2019)

Novel diagnostic model for bone metastases in renal cell carcinoma patients based on bone scintigraphy analyzed by computer-aided diagnosis software and bone turnover markers
por: Ujike, Takeshi, et al.
Publicado: (2022)

MicroRNA‐92b‐3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma
por: Wang, Cong, et al.
Publicado: (2020)

Increased level and fragmentation of plasma circulating cell-free DNA are diagnostic and prognostic markers for renal cell carcinoma
por: Yamamoto, Yoshiyuki, et al.
Publicado: (2018)

Decreased fucosylated PSA as a urinary marker for high Gleason score prostate cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2016)

Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder Cancer
por: Hayashi, Yujiro, et al.
Publicado: (2020)

Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinoma
por: Yamamoto, Yoshiyuki, et al.
Publicado: (2019)

Correction to: Primary adrenal lymphoma: three case reports and review of Japanese cases
por: Nakazawa, Shigeaki, et al.
Publicado: (2018)

Fragmentation of cell‐free DNA is induced by upper‐tract urothelial carcinoma–associated systemic inflammation
por: Nakano, Kosuke, et al.
Publicado: (2020)

Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial Carcinoma
por: Tomiyama, Eisuke, et al.
Publicado: (2020)

Proteomic analysis of urinary and tissue‐exudative extracellular vesicles to discover novel bladder cancer biomarkers
por: Tomiyama, Eisuke, et al.
Publicado: (2021)

Trop-2 in Upper Tract Urothelial Carcinoma
por: Tomiyama, Eisuke, et al.
Publicado: (2022)

Comparison of molecular profiles of upper tract urothelial carcinoma vs. urinary bladder cancer in the era of targeted therapy: a narrative review
por: Tomiyama, Eisuke, et al.
Publicado: (2022)

Intratumoral and s.c. injection of inactivated hemagglutinating virus of Japan envelope (GEN0101) in metastatic castration‐resistant prostate cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2020)

Selective arterial embolization for uncontrollable urethral hemorrhage in a patient with a left ventricular assist device
por: Hayashi, Yujiro, et al.
Publicado: (2018)

EMMPRIN Promotes Angiogenesis, Proliferation, Invasion and Resistance to Sunitinib in Renal Cell Carcinoma, and Its Level Predicts Patient Outcome
por: Sato, Mototaka, et al.
Publicado: (2013)

Perioperative circulating tumor DNA enables the identification of patients with poor prognosis in upper tract urothelial carcinoma
por: Nakano, Kosuke, et al.
Publicado: (2022)

Metastatic testicular cancer presenting with liver and kidney dysfunction treated with modified BEP chemotherapy combined with continuous hemodiafiltration and rasburicase
por: Kimakura, Mai, et al.
Publicado: (2016)

Peripheral T cell receptor repertoire features predict durable responses to anti-PD-1 inhibitor monotherapy in advanced renal cell carcinoma
por: Kato, Taigo, et al.
Publicado: (2021)

Genomic and Pathological Characterization of Multiple Renal Cell Carcinoma Regions in Patient With Tuberous Sclerosis Complex: A Case Report
por: Yamamoto, Tetsuya, et al.
Publicado: (2021)

Adjuvant chemotherapy improves survival of patients with high-risk upper urinary tract urothelial carcinoma: a propensity score-matched analysis
por: Fujita, Kazutoshi, et al.
Publicado: (2017)

TERT C228T mutation in non‐malignant bladder urothelium is associated with intravesical recurrence for patients with non‐muscle invasive bladder cancer
por: Hayashi, Yujiro, et al.
Publicado: (2020)

Obesity, Inflammation, and Prostate Cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2019)

Bacteria-derived DNA in serum extracellular vesicles are biomarkers for renal cell carcinoma
por: Uemura, Toshihiro, et al.
Publicado: (2023)

A case of mediastinal teratoma with malignant transformation into angiosarcoma and relapse with multiple bone metastases that was cured by a multidisciplinary treatment
por: Tani, Masaru, et al.
Publicado: (2022)

Tumour grade significantly correlates with total dysfunction of tumour tissue-infiltrating lymphocytes in renal cell carcinoma
por: Kawashima, Atsunari, et al.
Publicado: (2020)

Seronegative rheumatoid arthritis after combination therapy with ipilimumab and nivolumab for postoperative pancreatic and liver metastases from renal cell carcinoma
por: Nishimura, Yuki, et al.
Publicado: (2022)

Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma
por: Hayashi, Yujiro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_207jtd1do9g26ja853ltha24q0